PSG studies have demonstrated that orexin-A has a stabilizing effect on nocturnal sleep in a large clinical sample of patients with hypersomnia, and different cerebrospinal fluid (CSF) orexin-A levels correlate with nocturnal sleep/wake rhythms (28). This evidence concerns the gene HCRT and hypersomnia.